| Balance Sheets | 2025-09-30 | 2025-06-30 | ||
|---|---|---|---|---|
| Cash and cash equivalents | 2,782,758 | 588,775 | ||
| Accounts receivable and other receivables, net of allowance for doubtful accounts of 634,491 and 620,433 at september 30, 2025 and december 31, 2024, respectively | 120,931 | 372,469 | ||
| Prepaid expenses and other current assets | 698,122 | 204,926 | ||
| Total current assets | 3,601,811 | 1,166,170 | ||
| Property and equipment, gross | 436,082 | - | ||
| Accumulated depreciation | 393,416 | - | ||
| Property and equipment, net | 42,666 | 59,789 | ||
| Internally developed software, net | 4,483,800 | 3,876,518 | ||
| Other intangible assets, net | 573,034 | 620,923 | ||
| Operating lease right-of-use asset | 284,146 | 299,001 | ||
| Security deposits | 12,100 | 12,100 | ||
| Total assets | 8,997,557 | 6,034,501 | ||
| Accounts payable | 4,771,026 | 4,315,010 | ||
| Accrued expenses | 716,878 | 645,567 | ||
| Operating lease current obligation | 54,904 | 46,982 | ||
| Deferred revenue | 155,506 | 164,066 | ||
| Total current liabilities | 5,698,314 | 5,171,625 | ||
| Operating lease long-term obligation | 226,532 | 240,903 | ||
| Total liabilities | 5,924,846 | 5,412,528 | ||
| Common stock, 0.0001 par value, 200,000,000 shares authorized, 9,772,578 issued and 9,771,028 outstanding at september 30, 2025 and 1,698,454 issued and 1,696,904 outstanding at december 31, 2024 | 977 | 250 | ||
| Additional paid-in capital | 80,420,810 | 75,190,151 | ||
| Treasury stock, 1,550 shares at september 30, 2025 and december 31, 2024, at cost | 172 | 172 | ||
| Accumulated other comprehensive income | - | 0 | ||
| Accumulated deficit | -77,348,904 | -74,568,256 | ||
| Total stockholders equity | 3,072,711 | 621,973 | ||
| Total liabilities and stockholders equity | 8,997,557 | 6,034,501 | ||
iSpecimen Inc. (ISPC)
iSpecimen Inc. (ISPC)